{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"d-l-2-hydroxyglutaric-aciduria","columns":[{"gene":"","key":"population-2b16b922c5548c04bae0","label":"Combined D-2- and L-2-hydroxyglutaric aciduria","mondoId":"MONDO:0014072","onsetQualifier":null,"originColumnKey":"MONDO:0014072/OMIM:615182","originalViews":[{"key":"MONDO:0014072/OMIM:615182","label":"Combined D-2- and L-2-hydroxyglutaric aciduria","scopeLabel":"OMIM:615182","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0471bb9df737b0653ff116ba8b946d866d4525a793b97125921339d7c6e78c1c","0699d85d0f56b52e19121f862a6cdd68d32431808c86db4d2f34d57c95ef4435","0a12c7667e2811fe78ac0ec39b258249826d9ea657471ccbe0b53404987e1637","0ffa9647a2e9e636f29024b88fa89bbffd8843ac97ea05f87216ddfdcd8368f0","12372463a05c6ea4bc01423b0aa0e69c5af42f4ffae6f1f0a83e083757dae07f","1a8152f07f9469c9f5b7f534ac06073139b173b38d60e637938626ac4a3fd610","342d116c459d19533153bd6ae1e64e678e480118af416601e62b89edf1806635","3bdd400be8d6ad21166345ec072334b5caca894a166d8017a4570d922b3a9a74","67c09cac2ed6d73e3ac9115198a0df1384a4f0c6f0e359eb2858b63628ea4ce4","6b8d258b92ba2d69d6b2a2876f281f88b807f4a1336696e4eacf35ad3a4c016c","71918abea2704c3405b5ce4a5158abf67fe7e5ddda5c7cb7c16ee4f6e836eac4","80410d6acc94d64518ec34b147de779c47e0cc098c94c9674db09d6ee6e487e6","8160bbbaf8c6a2e212963dd8cd941432f0fbbc8b138339bc1b305d42d5f26f21","831539789ade94cad7a60b6c96c021322d913f935e72b64126b484acd7d372ba","8cd1f746c16930fd8ea8b87a8d32ee021fbe4eeca0827fbd5a8741bd661e38e7","967bb851e38a3d4380c82a900ef76030173454c603174b1b4988aa941ac09579","98db0fa096f3b767fbd9182f15561aab00f6a01cdc07be5c8b63b3d81b244aef","9fe8dd2e037cf39cbe9636e3c47eb7f92a4251e795a6267808042f056fabdf56","cdf16eb8427323b5a0ca136c7bd1aee67992868ca3645faaabd6e01131eb63c1","e05a70605a65308bb0839585562f32ddc2b8d4b8610c776be9afa64e73cc5914","e0e86e4447f953ea95c5d11817955b75e4d19644adfcb4c4fdc252e9060eabfb","e4ce58dd7e4bc5e925ec6a9a43f9a0f1a225a066aa78e18b64989cdc449854cc","f57c1974b381545d2ea3e36e8b23480fa2d690ab8b4601384092225ab66f9d42"],"recordQualifiers":{},"scopeLabel":"OMIM:615182","sourceIds":["OMIM:615182"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-2b16b922c5548c04bae0"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001321","HP:0100704","HP:0012448","HP:0002094","HP:6000246","HP:6000509","HP:0001298"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":6,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":23,"sourceGroups":{"omim":17,"published":6}},"features":[{"hpoId":"HP:0001321","label":"Cerebellar hypoplasia","primary":true},{"hpoId":"HP:0100704","label":"Cerebral visual impairment","primary":true},{"hpoId":"HP:0012448","label":"Delayed myelination","primary":true},{"hpoId":"HP:0002094","label":"Dyspnea","primary":true},{"hpoId":"HP:6000246","label":"Elevated CSF D-2-hydroxyglutaric acid concentration","primary":true},{"hpoId":"HP:6000509","label":"Elevated CSF L-2-hydroxyglutaric acid concentration","primary":true},{"hpoId":"HP:0001298","label":"Encephalopathy","primary":true},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0012402","label":"Increased urine alpha-ketoglutarate concentration","primary":false},{"hpoId":"HP:0033092","label":"Increased urine succinate level","primary":false},{"hpoId":"HP:0000737","label":"Irritability","primary":false},{"hpoId":"HP:0040144","label":"L-2-hydroxyglutaric aciduria","primary":false},{"hpoId":"HP:0000256","label":"Macrocephaly","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0000817","label":"Reduced eye contact","primary":false},{"hpoId":"HP:0002093","label":"Respiratory insufficiency","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0006829","label":"Severe muscular hypotonia","primary":false},{"hpoId":"HP:0010307","label":"Stridor","primary":false},{"hpoId":"HP:0002119","label":"Ventriculomegaly","primary":false}],"ledeHtml":"A rare inborn error of metabolism characterized by severe neonatal epileptic encephalopathy, episodes of apnea and respiratory distress, severe global developmental delay or absent psychomotor development, severe muscular hypotonia or absent voluntary movements, feeding difficulties and failure to thrive, absence of visual contact, abnormal brain morphology (including cerebral atrophy, ventriculomegaly and hypoplasia or dysplasia of the corpus callosum), mild dysmorphic features (frontal bossing, hypertelorism, downslanting palpebral fissures, flat nasal bridge), elevated cerebrospinal fluid (CSF) and plasma lactate and urinary Krebs cycle metabolites.","mondoId":"MONDO:0014072","node":{"canonicalSlug":"d-l-2-hydroxyglutaric-aciduria","comparisons":[{"documentSha256":"b29370411275f295db7fdff6e555648ed24bbddfdeb5b5354f7ca9857af0dcfa","key":"legacy-2-hydroxyglutaric-aciduria","kind":"legacy","label":"2-hydroxyglutaric aciduria","memberIds":["MONDO:0009370","MONDO:0010924","MONDO:0013345","MONDO:0014072","MONDO:0016001","MONDO:0024554"],"mondoId":"MONDO:0016001","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/2-hydroxyglutaric-aciduria.b29370411275f295db7fdff6e555648ed24bbddfdeb5b5354f7ca9857af0dcfa.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"D,L-2-hydroxyglutaric aciduria","originalSourceId":"ORPHA:356978","paragraphs":["A rare inborn error of metabolism characterized by severe neonatal epileptic encephalopathy, episodes of apnea and respiratory distress, severe global developmental delay or absent psychomotor development, severe muscular hypotonia or absent voluntary movements, feeding difficulties and failure to thrive, absence of visual contact, abnormal brain morphology (including cerebral atrophy, ventriculomegaly and hypoplasia or dysplasia of the corpus callosum), mild dysmorphic features (frontal bossing, hypertelorism, downslanting palpebral fissures, flat nasal bridge), elevated cerebrospinal fluid (CSF) and plasma lactate and urinary Krebs cycle metabolites."],"rawAttribution":"MONDO:0014072","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:26Z","upstream":"ORPHA:356978","url":"https://rarediseases.info.nih.gov/diseases/17540"},"ownColumnKeys":["population-2b16b922c5548c04bae0"],"publication":"published","relationships":[{"kind":"parent","label":"2-hydroxyglutaric aciduria","mondoId":"MONDO:0016001","slug":"2-hydroxyglutaric-aciduria"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"0471bb9df737b0653ff116ba8b946d866d4525a793b97125921339d7c6e78c1c","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002093","is_excluded":false,"label":"Respiratory insufficiency","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"0699d85d0f56b52e19121f862a6cdd68d32431808c86db4d2f34d57c95ef4435","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"PCS","frequency_raw":"9/11","hpo_id":"HP:0012402","is_excluded":false,"label":"Increased urine alpha-ketoglutarate concentration","onset_id":null,"reference":"PMID:23561848","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0a12c7667e2811fe78ac0ec39b258249826d9ea657471ccbe0b53404987e1637","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0040144","is_excluded":false,"label":"L-2-hydroxyglutaric aciduria","onset_id":null,"reference":"PMID:23561848","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0ffa9647a2e9e636f29024b88fa89bbffd8843ac97ea05f87216ddfdcd8368f0","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"PCS","frequency_raw":"7/8","hpo_id":"HP:0033092","is_excluded":false,"label":"Increased urine succinate level","onset_id":null,"reference":"PMID:23561848","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"12372463a05c6ea4bc01423b0aa0e69c5af42f4ffae6f1f0a83e083757dae07f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:6000509","is_excluded":false,"label":"Elevated CSF L-2-hydroxyglutaric acid concentration","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"1a8152f07f9469c9f5b7f534ac06073139b173b38d60e637938626ac4a3fd610","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000737","is_excluded":false,"label":"Irritability","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"342d116c459d19533153bd6ae1e64e678e480118af416601e62b89edf1806635","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"PCS","frequency_raw":"11/11","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:23561848","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"3bdd400be8d6ad21166345ec072334b5caca894a166d8017a4570d922b3a9a74","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000817","is_excluded":false,"label":"Reduced eye contact","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"67c09cac2ed6d73e3ac9115198a0df1384a4f0c6f0e359eb2858b63628ea4ce4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:6000246","is_excluded":false,"label":"Elevated CSF D-2-hydroxyglutaric acid concentration","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"6b8d258b92ba2d69d6b2a2876f281f88b807f4a1336696e4eacf35ad3a4c016c","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100704","is_excluded":false,"label":"Cerebral visual impairment","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"71918abea2704c3405b5ce4a5158abf67fe7e5ddda5c7cb7c16ee4f6e836eac4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"PMID:23561848","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"80410d6acc94d64518ec34b147de779c47e0cc098c94c9674db09d6ee6e487e6","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002094","is_excluded":false,"label":"Dyspnea","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"8160bbbaf8c6a2e212963dd8cd941432f0fbbc8b138339bc1b305d42d5f26f21","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"PCS","frequency_raw":"10/10","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"PMID:23561848","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"831539789ade94cad7a60b6c96c021322d913f935e72b64126b484acd7d372ba","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001298","is_excluded":false,"label":"Encephalopathy","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"8cd1f746c16930fd8ea8b87a8d32ee021fbe4eeca0827fbd5a8741bd661e38e7","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0010307","is_excluded":false,"label":"Stridor","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"967bb851e38a3d4380c82a900ef76030173454c603174b1b4988aa941ac09579","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"98db0fa096f3b767fbd9182f15561aab00f6a01cdc07be5c8b63b3d81b244aef","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012448","is_excluded":false,"label":"Delayed myelination","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"9fe8dd2e037cf39cbe9636e3c47eb7f92a4251e795a6267808042f056fabdf56","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"cdf16eb8427323b5a0ca136c7bd1aee67992868ca3645faaabd6e01131eb63c1","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0006829","is_excluded":false,"label":"Severe muscular hypotonia","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e05a70605a65308bb0839585562f32ddc2b8d4b8610c776be9afa64e73cc5914","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001321","is_excluded":false,"label":"Cerebellar hypoplasia","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e0e86e4447f953ea95c5d11817955b75e4d19644adfcb4c4fdc252e9060eabfb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002119","is_excluded":false,"label":"Ventriculomegaly","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e4ce58dd7e4bc5e925ec6a9a43f9a0f1a225a066aa78e18b64989cdc449854cc","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f57c1974b381545d2ea3e36e8b23480fa2d690ab8b4601384092225ab66f9d42","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:615182","disease_name":"Combined D-2- and L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000256","is_excluded":false,"label":"Macrocephaly","onset_id":null,"reference":"OMIM:615182","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17540\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014072\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:356978</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare inborn error of metabolism characterized by severe neonatal epileptic encephalopathy, episodes of apnea and respiratory distress, severe global developmental delay or absent psychomotor development, severe muscular hypotonia or absent voluntary movements, feeding difficulties and failure to thrive, absence of visual contact, abnormal brain morphology (including cerebral atrophy, ventriculomegaly and hypoplasia or dysplasia of the corpus callosum), mild dysmorphic features (frontal bossing, hypertelorism, downslanting palpebral fissures, flat nasal bridge), elevated cerebrospinal fluid (CSF) and plasma lactate and urinary Krebs cycle metabolites.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17540\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"d-l-2-hydroxyglutaric-aciduria","sourceDocuments":[{"name":"GARD: D,L-2-hydroxyglutaric aciduria","reviewed":null,"source_release":"2026-10-25T03:42:26Z","url":"https://rarediseases.info.nih.gov/diseases/17540"},{"name":"MONDO: D,L-2-hydroxyglutaric aciduria","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014072"}],"sourceNote":"","synonyms":["combined D-2- and L-2-hydroxyglutaric aciduria","combined D-2-hydroxyglutaric acidemia and L-2-hydroxyglutaric acidemia","combined D-2-hydroxyglutaric aciduria and L-2-hydroxyglutaric aciduria","D,L-2-HGA","D,L-2-hydroxyglutaric acidemia","D,L-2-hydroxyglutaric aciduria","D2L2AD"],"takeawayHtml":"","title":"D,L-2-hydroxyglutaric aciduria"},"schemaVersion":1}
